Specialists for Myelodysplastic/myeloproliferative disease

29 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Sanjay Mohan, MD, M.D
Rare Disease / Clinical Research
Vanderbilt-Ingram Cancer Center
NEW YORK, NY
QC-verified PI×3
Hagop Kantarjian, MD, MD
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×8
Minocher Battiwalla, MD, MD
Rare Disease / Clinical Research
National Institutes of Health- NHLBI
NASHVILLE, TN
PI×2
Farhad Ravandi-Kashani, M.D
Rare Disease / Clinical Research
SWOG Cancer Research Network
HOUSTON, TX
PI×8 2
Corey Cutler, MD, MPH, F.N.P
Rare Disease / Clinical Research
Dana-Farber Cancer Institute
PARK CITY, UT
PI×3
Farhad Ravandi-Kashani, MD, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
HOUSTON, TX
PI×11
Abhay Singh, MD, MPH
Rare Disease Specialist
Case Comprehensive Cancer Center, Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio
PI×1
Bart Scott
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
SEATTLE, WA
PI×3
Thomas G. Martin, MD
Rare Disease / Clinical Research
University of California, San Francisco
PI×4
Colleen Delaney, MD
Rare Disease / Clinical Research
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
OLD GREENWICH, CT
PI×3
Steven Devine, MD, MD
Rare Disease / Clinical Research
NMDP
LA CROSSE, WI
PI×4
Mikkael A Sekeres, MD
Rare Disease / Clinical Research
SWOG Cancer Research Network
MIAMI, FL
PI×1 3
Guillermo M Bravo, MD, MD
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
CHANDLER, AZ
PI×1 1
Francis Giles, M.D
Rare Disease / Clinical Research
M.D. Anderson Cancer Center
SAN ANTONIO, TX
PI×5
Susan K. Parsons, MD, MRP
Rare Disease / Clinical Research
Tufts Medical Center Cancer Center
PI×1
Claudio G. Brunstein, MD, PhD, M.D., PhD
Rare Disease / Clinical Research
Masonic Cancer Center, University of Minnesota
MINNEAPOLIS, MN
PI×6
Christopher Dvorak, PTA
Rare Disease / Clinical Research
Children's Oncology Group
AURORA, IL
PI×1
Mignon Loh, MD, M.D
Rare Disease / Clinical Research
University of California, San Francisco
SAN FRANCISCO, CA
PI×2
Margaret L. MacMillan, MD
Rare Disease / Clinical Research
Masonic Cancer Center, University of Minnesota
PI×4
James N Kochenderfer, M.D., MD
Rare Disease / Clinical Research
National Cancer Institute (NCI)
BETHESDA, MD
PI×7
Zaid Al Kadhimi, MD
Rare Disease / Clinical Research
The University of Alabama at Birmingham
PI×1
Raphaël Itzykson, MD
Rare Disease / Clinical Research
Saint-Louis Hospital, Paris, France
PI×1
Pierre Fenaux, MD, PHD
Rare Disease / Clinical Research
Saint-Louis Hospital, Paris, France
PI×1
Jürgen Wehmeyer, Dr.
Rare Disease / Clinical Research
Hämatologisch-onkologische Gemeinschaftspraxis
PI×1
Magnus Tobiasson
Nordic MDS Group
QC-verified PI×2
Olga Gurevitch
Hadassah Medical Organization
QC-verified PI×1
Linda Burns
Masonic Cancer Center, University of Minnesota
QC-verified PI×1
Amanda Cashen, MD
Mayo Clinic
SAINT LOUIS, MO
QC-verified PI×4
Sebastian Mayer, CRNA
Weill Medical College of Cornell University
ORLANDO, FL
QC-verified PI×1

More about Myelodysplastic/myeloproliferative disease